Skip to main content
. 2019 Sep 5;8(18):e013277. doi: 10.1161/JAHA.119.013277

Table 3.

Characteristics of the 4378 Patients With Intracranial Aneurysms

Variables for 4378 IA Patients From 1980 to 2015 125 Fusiform IA Patients Including 22 fIA Patients With Concomitant sIAs 450 First Degree Relatives to the fIA Patients 340 Matched Controls to the fIA Patients 4253 Saccular IA Patients With No fIAs 17 825 First Degree Relatives to the sIA Patients 12 669 Matched Controls to the sIA Patients P Value—Total fIA Vs Total sIAa
Unruptured fIA n=93 (64%) Ruptured fIA n=32 (26%) Total fIA n=125 0 fIA 1 sIA 0 fIA 1 sIA Unruptured sIA n=1330 (31%) Ruptured sIA n=2923 (69%) Total sIA n=4253 0 fIA 224 sIA (76 aSAH) 0 fIA 58 sIA (33 aSAH) <0.0005
Median age at IA diagnosis, y (25 and 75 percentiles) 66 (57 to 72) 59 (48 to 73) 64 (55 to 72) 47 at sIA 75 at sIA 57 (48 to 66) 52 (43 to 62) 54 (45 to 63) 47 (42 to 54) at sIA 56 (52 to 73) at sIA <0.0005
Presentation
Incidental 64 (69%) 1164 (88%) <0.0005
Symptomatic 29 (31%) 54 (4%)
sIA family screening 112 (8%)
Women, n (%) 39 (42%) 21 (66%) 60 (48%) 222 (49%) 160 (47%) 754 (57%) 1598 (55%) 2352 (55%) 8706 (49%) 7029 (55%) 0.106
sIA family, n (%) 5 (5%) 2 (6%) 7 (5.7%) 259 (20%) 314 (11%) 573 (14%) 0.007
Concomitant sIA, n (%) 22 sIA (18%)
Multiple fIAs (≥2), n (%) 7 (8%) 1 (3%) 8 (6%)
Multiple sIAs (≥2), n (%) 9 (10%) 0 (0%) 9 (7%) 380 (29%) 811 (28%) 1191 (28%)
AAA total 9 (10%) 9 (7%) 2 (0.4%) 4 (0.6%) 24 (2%) 13 (0.4%) 37 (1%) 35 (0.2%) 54 (0.4%) <0.0005
Ruptured 2 (2%) 2 (2%) 2 (0.2%) 6 (0.2%) 8 (0.2%) 11 (0.1%) 12 (0.1%)
Confirmed TAA total 1 (1%) 1 (1%) 2 (0.4%) 8 (0.6%) 2 (0.1%) 10 (0.2%) 12 (0.1%) 10 (0.1%) 0.273
Ruptured 4 (0.0%) 1 (0.0%)
Suspected TAA 3 (4%) 1 (3%) 4 (4%)
AAA + TAA total 3 (3%) 3 (2%) 2 (0.0%) 1 (0.0%)
Ruptured 1 (1%) 1 (1%)
Unspecified AA 1 (0.0%) 10 (0.1%) 3 (0.0%)
Dissection 1 (1%) 1 (1%) 2 (0.4%) 2 (0.1%) 2 (0.0%) 5 (0.0%) 18 (0.1%) 0.08
AA or dissection 17 (18%) 1 (3%) 18 (14%) 6 (1%) 4 (1%) 27 (2%) 16 (0.1%) 50 (1%) 64 (0.4%) 86 (0.7%) <0.0005
Ruptured 3 (3%) 3 (2%) 2 (0.0%) 5 (0.0%) 8 (0.0%) 15 (0.1%) 13 (0.1%)
Median age at AA diagnosis, y (25 and 75 percentiles) 63 (58 to 73) 50 (46 to 54) 76 (73 to 81) 65 (59 to 73) 66 (58 to 72) 70 (63 to 76) 0.61
Comorbid diseases in IA patients from 1995 to 2014 n=69 n=20 n=89 n=405 n=251 n=1142 n=1580 n=2722 n=15 652 n=10 391
ADPKD, n (%) 1 (1%) 1 (3%) 2 (2%) 0 0 19 (1%) 32 (1%) 51 (1%) 33 (0.2%) 7 (0.1%) 0.663
Marfan, n (%) 0 0 0 0 0 0 0 0 3 (0.0%) 1 (0.0%)
Loeys‐Dietz, n (%) 0 0 0 0 0 0 0 0 0 0
Ehlers‐Danlos, n (%) 0 0 0 0 0 0 0 0 0 0
Hypertension, n (%) 63 (91%) 18 (90%) 81 (91%) 146 (45%) 245 (97%) 921 (81%) 1123 (71%) 2044 (75%) 8780 (56%) 7989 (77%) 0.001
Type 2 diabetes mellitus, n (%) 15 (22%) 5 (25%) 20 (22%) 34 (8%) 61 (24%) 174 (15%) 187 (12%) 361 (13%) 2270 (14%) 1742 (17%) 0.012
Atherosclerotic disease or hyperlipidemia 23 (25%) 3 (9%) 37 (30%) 98 (24%) 172 (68%) 187 (16%) 158 (10%) 345 (13%) 5764 (37%) 5132 (49%) <0.0005

AA indicates aortic aneurysm; AAA, abdominal aortic aneurysm; ADPKD, autosomal dominant polycystic kidney disease; aSAH, aneurysmal subarachnoid haemorrhage; fIA, fusiform intracranial aneurysm; IA, intracranial aneurysm; sIA saccular intracranial aneurysm; TAA, thoracic aortic aneurysm.

a

Statistical significance calculated for the difference of the total fIA and sIA groups.